Cite

    Bilen, M. et al. (2016). Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody. Journal for immunotherapy of cancer. 4 (1), pp. 1-5. [Online].